Comment
doi: 10.1111/j.1365-2133.2011.10420.x.
Methotrexate, a drug for the years to come
Affiliations
- PMID: 21777212
- DOI: 10.1111/j.1365-2133.2011.10420.x
Item in Clipboard
Comment
Methotrexate, a drug for the years to come
Br J Dermatol.
2011 Aug.
No abstract available
Comment on
-
Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study.Br J Dermatol. 2011 Aug;165(2):399-406. doi: 10.1111/j.1365-2133.2011.10399.x. Epub 2011 Jul 11. Br J Dermatol. 2011. PMID: 21564071 Clinical Trial.
Similar articles
-
The METOP Study: Further Evidence for the Use of Subcutaneous Methotrexate in Psoriasis.Actas Dermosifiliogr. 2017 Nov;108(9):865-866. doi: 10.1016/j.ad.2017.04.007. Epub 2017 Jun 3. Actas Dermosifiliogr. 2017. PMID: 28583269 English, Spanish. No abstract available.
-
[Methotrexate in psoriasis: do we need to give a test dose?].Actas Dermosifiliogr. 2012 Jan-Feb;103(1):1-4. doi: 10.1016/j.ad.2011.05.008. Epub 2011 Nov 16. Actas Dermosifiliogr. 2012. PMID: 22093543 Spanish. No abstract available.
-
Split doses of Methotrexate in patients with moderate to severe Psoriasis.Actas Dermosifiliogr. 2017 Jul-Aug;108(6):603-604. doi: 10.1016/j.ad.2016.12.004. Epub 2017 Feb 4. Actas Dermosifiliogr. 2017. PMID: 28173920 English, Spanish. No abstract available.
-
Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?Am J Clin Dermatol. 2005;6(6):357-63. doi: 10.2165/00128071-200506060-00003. Am J Clin Dermatol. 2005. PMID: 16343024 Review.
-
Treatment of psoriasis. Part 2. Systemic therapies.J Am Acad Dermatol. 2001 Nov;45(5):649-61; quiz 662-4. doi: 10.1067/mjd.2001.117047. J Am Acad Dermatol. 2001. PMID: 11606913 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
